Comparative Efficacy of the Generalized Anxiety Disorder 7-Item Scale and the Edinburgh Postnatal Depression Scale as Screening Tools for Generalized Anxiety Disorder in Pregnancy and the Postpartum Period
Free accessResearch articleFirst published online August, 2014
Comparative Efficacy of the Generalized Anxiety Disorder 7-Item Scale and the Edinburgh Postnatal Depression Scale as Screening Tools for Generalized Anxiety Disorder in Pregnancy and the Postpartum Period
About 24.1% of pregnant women suffer from at least 1 anxiety disorder, 8.5% of whom suffer specifically from generalized anxiety disorder (GAD). GAD is often associated with major depressive disorder (MDD). During the perinatal period, the presence of physical and somatic symptoms often makes differentiation between depression and anxiety more challenging. To date, no screening tools have been developed to detect GAD in the perinatal population. We investigated the psychometric properties of the GAD 7-item Scale (GAD-7) as a screening tool for GAD in pregnant and postpartum women.
Methods:
Two hundred and forty perinatal women (n = 155 pregnant and n = 85 postpartum) referred for psychiatric consultation were enrolled. On the day of initial assessment, all women completed the GAD-7 and the Edinburgh Postnatal Depression Scale (EPDS). Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition–based diagnoses were made by experienced psychiatrists. Scores from the GAD-7 and EPDS were compared with the clinical diagnoses to evaluate the psychometric properties of the GAD-7 and EPDS when used as a screening tool for GAD.
Results:
The GAD-7 yielded a sensitivity of 61.3% and specificity of 72.7% at an optimal cut-off score of 13. Compared with the EPDS and the EPDS-3A subscale, the GAD-7 displayed greater accuracy and specificity over a greater range of cut-off scores and more accurately identified GAD in patients with comorbid MDD.
Conclusion:
Our findings suggest that the GAD-7 represents a clinically useful scale for the detection of GAD in perinatal women.
KesslerRCBerglundPDemlerO, Lifetime prevalence and age-of-onset distributions' of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593–602.
2.
YonkersKAWarshawMGMassionAO, Phenomenology and course of generalised anxiety disorder. Br J Psychiatry. 1996;168(3):308–313.
3.
FricchioneG.Generalized anxiety disorder. N Engl J Med. 2004;351(7):675–682.
4.
BrownTAO'LearyTABarlowDH. Clinical handbook of psychological disorders: A step-by-step treatment manual. 3rd ed.New York (NY): Guilford Press; 2001.
5.
BlazerDHughesDGeorgeLK. Stressful life events and the onset of a generalized anxiety syndrome. Am J Psychiatry. 1987;144(9):1178–1183.
6.
KarsnitzDBWardS.Spectrum of anxiety disorders: Diagnosis and pharmacologic treatment. J Midwifery Womens Health. 2011;56(3):266–281.
7.
KesslerRCKellerMBWittchenH.The epidemiology of generalized anxiety disorder. Psychiatr Clin North Am. 2001;24(1):19–39.
8.
Vesga-LopezOSchneierFRWangS, Gender differences in generalized anxiety disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). J Clin Psychiatry. 2008;69(10):1606–1616.
9.
KesslerRMcGonagleKZhaoS, Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51(1):8–19.
10.
GaterRTansellaMKortenA, Sex differences in the prevalence and detection of depressive and anxiety disorders in general health care settings: Report from the World Health Organization Collaborative Study on psychological problems in general health care. Arch Gen Psychiatry. 1998;55(5):405–413.
11.
BijlRRavelliAvan ZessenG.Prevalence of psychiatric disorder in the general population: Results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc Psychiatry Psychiatr Epidemiol. 1998;33(12):587–595.
12.
CarterRMWittchenHPfisterH, One-year prevalence of subthreshold and threshold DSM-IV generalized anxiety disorder in a nationally representative sample. Depress Anxiety. 2001;13(2):78–88.
13.
Sutter-DallayAGiaconne-MarcescheVGlatigny-DallayE, Women with anxiety disorders during pregnancy are at increased risk of intense postnatal depressive symptoms: A prospective survey of the MATQUID cohort. Eur Psychiatry. 2004;19(8):459–463.
14.
BallardCDavisRCullenP, Prevalence of postnatal psychiatric morbidity in mothers and fathers. Br J Psychiatry. 1994;164(6):782–788.
15.
WenzelAHaugenEJacksonL, Prevalence of generalized anxiety at eight weeks postpartum. Arch Womens Ment Health. 2003;6(1):43–49.
16.
WenzelAHaugenENJacksonLC, Anxiety symptoms and disorders at eight weeks postpartum. J Anxiety Disord. 2005;19(3):295–311.
17.
KesslerRCChiuWTDemlerO, Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):617–627.
18.
WeisbergRBPaquetteJA. Screening and treatment of anxiety disorders in pregnant and lactating women. Womens Health Issues. 2002;12(1):32–36.
19.
KesslerRCDuPontRLBerglundP, Impairment in pure and comorbid generalized anxiety disorder and major depression at 12 months in two national surveys. Am J Psychiatry. 1999;156(12):1915–1923.
20.
LiebRBeckerEAltamuraC.The epidemiology of generalized anxiety disorder in Europe. Eur Neuropsychopharmacol. 2005;15(4):445–452.
21.
AlonsoJLepineJ, ESEMeD/MHEDEA 2000 Scientific Comm. Overview of key data from the European Study of the Epidemiology of Mental Disorders (ESEMeD). J Clin Psychiatry. 2007;68(2 Suppl):3–9.
22.
GabilondoARojas-FarrerasSVilagutG, Epidemiology of major depressive episode in a southern European country: Results from the ESEMeD-Spain project. J Affect Disord. 2010;120(1):76–85.
23.
NoyesR.Comorbidity in generalized anxiety disorder. Psychiatr Clin North Am. 2001;24(1):41–55.
24.
BruceSEYonkersKAOttoMW, Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: A 12-year prospective study. Am J Psychiatry. 2005;162(6):1179–1187.
25.
FichterMMQuadfliegNFischerUC, Twenty-five-year course and outcome in anxiety and depression in the Upper Bavarian Longitudinal Community Study. Acta Psychiatr Scand. 2010;122(1):75–85.
26.
van Batenburg-EddesTde GrootLHuizinkAC, Maternal symptoms of anxiety during pregnancy affect infant neuromotor development: The Generation R Study. Dev Neuropsychol. 2009;34(4):476–493.
27.
DiPietroJA. Maternal stress in pregnancy: Considerations for fetal development. J Adolesc Health. 2012;51(2 Suppl):S3–S8. doi: 10.1016/j.jadohealth.2012.04.008.
28.
CoxJLHoldenJMSagovskyR.Detection of postnatal depression—development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry. 1987;150:782–786.
29.
GrigoriadisSde Camps MeschinoDBarronsE, Mood and anxiety disorders in a sample of Canadian perinatal women referred for psychiatric care. Arch Womens Ment Health. 2011;14(4):325–333.
30.
MattheyS.Using the Edinburgh Postnatal Depression Scale to screen for anxiety disorders. Depress Anxiety. 2008;25(11):926–931.
31.
PhillipsJCharlesMSharpeL, Validation of the subscales of the Edinburgh Postnatal Depression Scale in a sample of women with unsettled infants. J Affect Disord. 2009;118(1):101–112.
32.
SpitzerRLKroenkeKWilliamsJB, A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch Intern Med. 2006;166(10):1092–1097.
33.
ChristensenHBatterhamPGrantJ, A population study comparing screening performance of prototypes for depression and anxiety with standard scales. BMC Med Res Methodol. 2011;11:154. doi: 10.1186/1471-2288-11-154.
34.
KertzSBigda-PeytonJBjorgvinssonT.Validity of the Generalized Anxiety Disorder-7 Scale in an acute psychiatric sample. Clin Psychol Psychother. 2013;20(5):456–464. doi: 10.1002/cpp.1802. Epub 2012 May 17.
35.
BlackerDEndicottJ.Psychometic properties. In: RushAJJrFirstMBBlackerD, editors. Handbook of psychiatric measures. Washington (DC): American Psychiatric Publishing; 2000.
36.
MattheySHenshawCElliottS, Variability in use of cut-off scores and formats on the Edinburgh Postnatal Depression Scale: Implications for clinical and research practice. Arch Womens Ment Health. 2006;9(6):309–315.
37.
Eberhard-GranMEskildATambsK, Review of validation studies of the Edinburgh Postnatal Depression Scale. Acta Psychiatr Scand. 2001;104(4):243–249.
38.
FischerJEBachmannLMJaeschkeR.A readers' guide to the interpretation of diagnostic test properties: Clinical example of sepsis. Intensive Care Med. 2003;29(7):1043–1051.
39.
StreinerDLCairneyJ.What's under the ROC? An introduction to receiver operating characteristic curves. Can J Psychiatry. 2007;52(2):121–128.
40.
MeadesRAyersS.Anxiety measures validated in perinatal populations: A systematic review. J Affect Disord. 2011;133(1):1–15.
41.
MattheySValentiBSouterK, Comparison of four self-report measures and a generic mood question to screen for anxiety during pregnancy in English-speaking women. J Affect Disord. 2013;148(2–3):347–51. doi: 10.1016/j.jad.2012.12.022. Epub 2013 Feb 4.
42.
AbiodunOA. A validity study of the Hospital Anxiety and Depression Scale in general hospital units and a community sample in Nigeria. Br J Psychiatry. 1994;165(5):669–672.
43.
DonkerTComijsHCuijpersP, The validity of the Dutch K10 and extended K10 screening scales for depressive and anxiety disorders. Psychiatr Res. 2010;176(1):45–50.
44.
GoldbergDPGaterRSartoriusN, The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychol Med. 1997:27(1):191–197.
